Millennium Management’s Aratana Therapeutics, Inc. PETX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-293,333
| Closed | -$1.51M | – | 4786 |
|
|
2019
Q2 | $1.51M | Buy |
293,333
+176,753
| +152% | +$794K | ﹤0.01% | 2573 |
|
|
2019
Q1 | $420K | Sell |
116,580
-526,343
| -82% | -$2.28M | ﹤0.01% | 3379 |
|
|
2018
Q4 | $3.94M | Buy |
642,923
+346,243
| +117% | +$2.11M | 0.01% | 1747 |
|
|
2018
Q3 | $1.73M | Sell |
296,680
-238,308
| -45% | -$1.19M | ﹤0.01% | 2536 |
|
|
2018
Q2 | $2.27M | Sell |
534,988
-812,987
| -60% | -$4.1M | ﹤0.01% | 2307 |
|
|
2018
Q1 | $5.95M | Buy |
1,347,975
+726,903
| +117% | +$3.24M | 0.01% | 1691 |
|
|
2017
Q4 | $3.27M | Buy |
+621,072
| New | +$3.8M | ﹤0.01% | 1974 |
|
|
2017
Q3 | – | Sell |
-47,206
| Closed | -$341K | – | 4076 |
|
|
2017
Q2 | $341K | Buy |
+47,206
| New | +$290K | ﹤0.01% | 2993 |
|
|
2017
Q1 | – | Sell |
-121,761
| Closed | -$874K | – | 4020 |
|
|
2016
Q4 | $874K | Sell |
121,761
-147,823
| -55% | -$1.2M | ﹤0.01% | 2326 |
|
|
2016
Q3 | $2.52M | Buy |
+269,584
| New | +$2.24M | ﹤0.01% | 1803 |
|
|
2016
Q2 | – | Sell |
-364,353
| Closed | -$2.01M | – | 3796 |
|
|
2016
Q1 | $2.01M | Sell |
364,353
-631,030
| -63% | -$2.37M | 0.01% | 1769 |
|
|
2015
Q4 | $5.55M | Buy |
995,383
+758,484
| +320% | +$5.01M | 0.01% | 1292 |
|
|
2015
Q3 | $2M | Buy |
236,899
+52,554
| +29% | +$889K | ﹤0.01% | 1899 |
|
|
2015
Q2 | $2.79M | Buy |
184,345
+116,943
| +174% | +$1.69M | 0.01% | 1717 |
|
|
2015
Q1 | $1.08M | Sell |
67,402
-34,402
| -34% | -$612K | ﹤0.01% | 2270 |
|
|
2014
Q4 | $1.81M | Sell |
101,804
-87,294
| -46% | -$1.09M | ﹤0.01% | 2048 |
|
|
2014
Q3 | $1.9M | Buy |
189,098
+90,832
| +92% | +$1.1M | ﹤0.01% | 1901 |
|
|
2014
Q2 | $1.53M | Sell |
98,266
-1,976
| -2% | -$28K | ﹤0.01% | 1940 |
|
|
2014
Q1 | $1.86M | Buy |
100,242
+33,868
| +51% | +$679K | 0.01% | 1838 |
|
|
2013
Q4 | $1.27M | Buy |
+66,374
| New | +$1.35M | ﹤0.01% | 2132 |
|
Other funds holding PETX
Millennium Management's PETX Position: Q3 2019 in Review
Millennium Management sold out of Aratana Therapeutics, Inc. (PETX) in Q3 2019, closing a stake of 293,333 shares — an estimated $1.51M sold.
Millennium Management first reported a position in PETX in Q4 2013 and held it in 20 quarters. The position peaked at $5.95M in Q1 2018. 2 funds tracked by Wall St. Rank hold PETX as of Q3 2019.
- Millennium Management reported no remaining Aratana Therapeutics, Inc. position as of Q3 2019 after selling out during the quarter.
- Millennium Management sold 293,333 Aratana Therapeutics, Inc. shares in Q3 2019, an estimated $1.51M.
- Millennium Management first reported a position in Aratana Therapeutics, Inc. in Q4 2013 and held it in 20 quarters.
- Millennium Management's Aratana Therapeutics, Inc. position peaked at $5.95M in Q1 2018.
- 2 funds tracked by Wall St. Rank held Aratana Therapeutics, Inc. as of Q3 2019.
Based on Millennium Management's 13F filing for Q3 2019, filed 14 Nov 2019.